BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 130 filers reported holding BIOLIFE SOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,352,737 | +582.8% | 242,776 | +1024.0% | 0.03% | +466.7% |
| Q3 2022 | $491,000 | +63.1% | 21,600 | -0.9% | 0.01% | +100.0% |
| Q2 2022 | $301,000 | -85.9% | 21,800 | -62.0% | 0.00% | -81.2% |
| Q4 2021 | $2,136,000 | -73.0% | 57,300 | -69.4% | 0.02% | -72.9% |
| Q3 2021 | $7,920,000 | -3.9% | 187,156 | +1.1% | 0.06% | +3.5% |
| Q2 2021 | $8,243,000 | -24.1% | 185,196 | -38.6% | 0.06% | -21.9% |
| Q1 2021 | $10,854,000 | -67.8% | 301,496 | -64.3% | 0.07% | -73.8% |
| Q4 2020 | $33,712,000 | +37.8% | 845,116 | 0.0% | 0.28% | +5.7% |
| Q3 2020 | $24,458,000 | +120.1% | 845,116 | +24.4% | 0.26% | +116.4% |
| Q2 2020 | $11,112,000 | +143.3% | 679,616 | +41.4% | 0.12% | +96.8% |
| Q1 2020 | $4,567,000 | +27.9% | 480,716 | +117.8% | 0.06% | +93.8% |
| Q4 2019 | $3,571,000 | +9.2% | 220,716 | +12.2% | 0.03% | +6.7% |
| Q3 2019 | $3,269,000 | +3.3% | 196,655 | +5.4% | 0.03% | +3.4% |
| Q2 2019 | $3,164,000 | – | 186,655 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,780,000 | $107,441,800 | 11.89% |
| Gagnon Advisors, LLC | 360,758 | $4,982,067 | 4.17% |
| Meros Investment Management, LP | 372,203 | $5,140,123 | 2.80% |
| Park West Asset Management LLC | 2,014,954 | $27,826,515 | 2.56% |
| GAGNON SECURITIES LLC | 633,363 | $8,746,743 | 2.19% |
| Mesirow Financial Investment Management, Inc. | 26,710 | $368,865 | 1.60% |
| Roubaix Capital, LLC | 146,898 | $2,028,661 | 1.50% |
| Millrace Asset Group, Inc. | 48,917 | $676 | 0.84% |
| Soleus Capital Management, L.P. | 439,000 | $6,062,590 | 0.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,363,638 | $18,831,841 | 0.53% |